BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park H, Otte A, Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release 2021;342:53-65. [PMID: 34971694 DOI: 10.1016/j.jconrel.2021.12.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Shaputkin ED, Nifant'ev IE, Bagrov VV, Shlyakhtin AV, Abashkin DA, Galiakberova AA, Ivchenko PV. Lipophilic poly(glycolide) blocks in morpholin-2-one-based CARTs for plasmid DNA delivery: Polymer regioregularity, sequence of lipophilic/polyamine blocks, and nanoparticle stability as factors of transfection efficiency. European Polymer Journal 2022;181:111644. [DOI: 10.1016/j.eurpolymj.2022.111644] [Reference Citation Analysis]
2 Liu J, Li X, Zhang X, Wang R, Han S, Qin P, Xing X, Zhang C. Gut lumen-targeted oral delivery system for bioactive agents to regulate gut microbiome. Journal of Future Foods 2022;2:307-325. [DOI: 10.1016/j.jfutfo.2022.08.003] [Reference Citation Analysis]
3 Ramasundaram S, Sobha S, Saravanakumar G, Oh TH. Recent Advances in Biomedical Applications of Polymeric Nanoplatform Assisted with Two-Photon Absorption Process. Polymers 2022;14:5134. [DOI: 10.3390/polym14235134] [Reference Citation Analysis]
4 Khare P, Conway JF, S Manickam D. Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells. European Journal of Pharmaceutics and Biopharmaceutics 2022;180:238-250. [DOI: 10.1016/j.ejpb.2022.10.011] [Reference Citation Analysis]
5 Goldmünz E, Aserin A, Garti N. The Effect of the Structural Transition within a Direct Hexagonal (HI) Mesophase on the Internal Lipid Mobility. Journal of Molecular Liquids 2022. [DOI: 10.1016/j.molliq.2022.120742] [Reference Citation Analysis]
6 He Y, Zhang W, Xiao Q, Fan L, Huang D, Chen W, He W. Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.11.002] [Reference Citation Analysis]
7 Sun K, Zheng X, Jin H, Yu F, Zhao W. Exosomes as CNS Drug Delivery Tools and Their Applications. Pharmaceutics 2022;14:2252. [PMID: 36297688 DOI: 10.3390/pharmaceutics14102252] [Reference Citation Analysis]
8 Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, Eskitzis P, Zarogoulidis P, Kosmidis C, Matthaios D, Porpodis K. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy. Front Oncol 2022;12:1042125. [DOI: 10.3389/fonc.2022.1042125] [Reference Citation Analysis]
9 Hale MM, Medina SH. Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies. Mol Pharm 2022. [PMID: 36149250 DOI: 10.1021/acs.molpharmaceut.2c00626] [Reference Citation Analysis]
10 Salvador J, Berthelot J, Bony C, Robin B, Him JLK, Noël D, Belamie E, Morille M. Size-tunable lipid vectors for controlled local delivery of siRNA from gene activated matrix. Acta Biomater 2022:S1742-7061(22)00579-7. [PMID: 36113724 DOI: 10.1016/j.actbio.2022.09.016] [Reference Citation Analysis]
11 Chen Z, Chen X, Huang J, Wang J, Wang Z. Harnessing Protein Corona for Biomimetic Nanomedicine Design. Biomimetics 2022;7:126. [DOI: 10.3390/biomimetics7030126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Li Y, Yao R, Ren M, Yuan K, Du Y, He Y, Kang H, Yuan S, Ju W, Qiao J, Xu K, Zeng L. Liposomes trigger bone marrow niche macrophage "foam" cell formation and affect hematopoiesis in mice. J Lipid Res 2022;:100273. [PMID: 36084713 DOI: 10.1016/j.jlr.2022.100273] [Reference Citation Analysis]
13 Wang S, Wang Y, Jin K, Zhang B, Peng S, Nayak AK, Pang Z. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2108786] [Reference Citation Analysis]
14 De Jong WH, Geertsma RE, Borchard G. Regulatory safety evaluation of nanomedical products: key issues to refine. Drug Deliv Transl Res 2022. [PMID: 35908133 DOI: 10.1007/s13346-022-01208-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dong S, Zhang Y, Guo X, Zhang C, Wang Z, Yu J, Liu Y, Li C, Hu Y, Sun B, Sun M, Zhang H, Ouyang D, He Z, Wang Y. Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction-Sensitive Nanoparticles at the "Cellular Level" and Synergize PD-1 Blockade Therapy. Adv Sci (Weinh) 2022;:e2202744. [PMID: 35896947 DOI: 10.1002/advs.202202744] [Reference Citation Analysis]
16 Holsæter AM, Wizgird K, Karlsen I, Hemmingsen JF, Brandl M, Škalko-Basnet N. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study. Eur J Pharm Sci 2022;177:106267. [PMID: 35872073 DOI: 10.1016/j.ejps.2022.106267] [Reference Citation Analysis]
17 Watanabe G, Lieber MR, Williams DR. Structural analysis of the basal state of the Artemis:DNA-PKcs complex. Nucleic Acids Res 2022:gkac564. [PMID: 35801871 DOI: 10.1093/nar/gkac564] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Wilkinson J, Ajulo D, Tamburrini V, Gall GL, Kimpe K, Holm R, Belton P, Qi S. Lipid based intramuscular long-acting injectables: current state of the art. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106253] [Reference Citation Analysis]
19 Minehan RL, Del Borgo MP. Controlled Release of Therapeutics From Enzyme-Responsive Biomaterials. Front Biomater Sci 2022;1. [DOI: 10.3389/fbiom.2022.916985] [Reference Citation Analysis]
20 Kim M, Kim JH, Kim S, Maharjan R, Kim NA, Jeong SH. New long-acting injectable microspheres prepared by IVL-DrugFluidic™ system: 1-month and 3-month in vivo drug delivery of leuprolide. Int J Pharm 2022;622:121875. [PMID: 35636628 DOI: 10.1016/j.ijpharm.2022.121875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li M, Gao Z, Cui J. Modulation of Colloidal Particle Stiffness for the Exploration of Bio-Nano Interactions. Langmuir 2022. [PMID: 35617605 DOI: 10.1021/acs.langmuir.2c01117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rebanda MM, Bettini S, Blasi L, Gaballo A, Ragusa A, Quarta A, Piccirillo C. Poly(l-lactide-co-caprolactone-co-glycolide)-Based Nanoparticles as Delivery Platform: Effect of the Surfactants on Characteristics and Delivery Efficiency. Nanomaterials (Basel) 2022;12:1550. [PMID: 35564258 DOI: 10.3390/nano12091550] [Reference Citation Analysis]
23 Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M, Wang L, Sun T, Li N, Han L, Shi J, Huang Y, Guo W, Peng S, Zhou W, Gao H. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
24 Cascallar M, Alijas S, Pensado-lópez A, Vázquez-ríos AJ, Sánchez L, Piñeiro R, de la Fuente M. What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine. Cancers 2022;14:2238. [DOI: 10.3390/cancers14092238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang C, Zhu X, Hou S, Pan W, Liao W. Functionalization of Nanomaterials for Skin Cancer Theranostics. Front Bioeng Biotechnol 2022;10:887548. [DOI: 10.3389/fbioe.2022.887548] [Reference Citation Analysis]
26 Khare P, Conway JF, Manickam DS. Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells.. [DOI: 10.1101/2022.04.07.487513] [Reference Citation Analysis]
27 Chen Q, Su L, He X, Li J, Cao Y, Wu Q, Qin J, He Z, Huang X, Yang H, Li J. Poly(beta-amino ester)-Based Nanoparticles Enable Nonviral Delivery of Base Editors for Targeted Tumor Gene Editing. Biomacromolecules 2022. [PMID: 35388688 DOI: 10.1021/acs.biomac.2c00137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Park K, Otte A, Park H. Perspective on drug delivery in 2050. J Control Release 2022:S0168-3659(22)00099-2. [PMID: 35202744 DOI: 10.1016/j.jconrel.2022.02.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2022. [DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]